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F.B., T.B.).D ear Editor—We read the interesting letter of Khaliliet al. about the role of lung ultrasound (LU) indiagnosing COVID-19 interstitial pneumonia dur-
ing the recent SARS-CoV-2 global outbreak (1). We would
like to present our different point of view. The Authors, after
listing some of the benefits of LU, argue that it suffers from
lower sensitivity than computed tomography (CT) and for
this reason, it would not be useful in the diagnosis of
COVID-19 pneumonia. However, Yang et al. compared LU
and CT on 29 patients (for 540 lung regions) (2) and found
that LU was more sensitive than CT in the diagnosis of
regional alveolar-interstitial pattern, alveolar-interstitial syn-
drome, consolidations, and pleural effusion (60% vs. 38.5%;
93% vs. 69%; 39% vs. 3% and 74% vs. 16%, respectively).
Khalili et al. correctly report that the most common imagin-
ing finding in COVID-19 pneumonia is widespread intersti-
tial involvement. Therefore, we see no reason why LU
cannot be used for the diagnosis of COVID-19 pneumonia,
considering its comparable sensitivity, even superior to the
CT scan. Furthermore, the recent study by Almeida Mon-
teiro et al. confirmed the correlation between histological
findings on lung biopsy and LU images (3). This report not
only supports the correctness of the hypothesis (and his clini-
cal and LU observations) of Volpicelli et al. (4) but also con-
firms the high sensitivity of LU in diagnosing COVID-19
pneumonia at different stages.
The second aspect that Khalili et al. seem not to have taken
sufficiently into account is the prevalence of the disease during
the COVID-19 epidemic peak. The medical chief of the Emer-
gency Department of the main hospital in Bergamo reported
seeing up to 6080 suspected patients for COVID-19 in only a
few hours (5). We do not know the size and resources of the
hospital structure in which Khalili and colleagues work, but the
execution of 30 CT scans per hour is simply inconceivable. In
these circumstances the high sensitivity of LU (together with its
safety, the possibility of performing it at the patient's bedside and
of avoiding the transfer of a potentially infected patient around
the hospital) is precisely the characteristic that makes LU thepreferred tool for mass triage (6). Even though the incidence of
COVID-19 seems to have decreased, and it is essential to be
able to rule out lung involvement by COVID-19 in a vast por-
tion of the asymptomatic population, LU appears to be the tool
of choice. We have repeatedly stressed in our previous papers
that LU does not seem to be adequately specific for COVID-19
pneumonia (7-9). But in this regard, a recent meta-analysis
reports a very low specificity even for CT scan (10). Therefore,
the specificity game between LU and CT scan is far from over.
On one point, we agree with Khalili and colleagues: it would
take adequately sized studies to establish the diagnostic accuracy
of LU in terms of sensitivity and specificity. But we are confi-
dent that these studies will be soon available.AUTHORS’ CONTRIBUTIONS
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